What is Global Adjunctive Haemostats Market?
The Global Adjunctive Haemostats Market refers to the worldwide market for medical products designed to control bleeding during surgical procedures. These products, known as adjunctive haemostats, are used to enhance the body's natural ability to stop bleeding. They are particularly useful in surgeries where traditional methods, such as sutures or cauterization, are insufficient or impractical. The market includes a variety of haemostatic agents, such as liquid substances, gelatins, thrombins, oxidized regenerated cellulose, and powder haemostats. These products are essential in ensuring patient safety and improving surgical outcomes by minimizing blood loss and reducing the risk of complications. The global demand for adjunctive haemostats is driven by the increasing number of surgical procedures, advancements in medical technology, and the growing awareness of the benefits of these products among healthcare professionals. As a result, the market is expected to continue expanding, offering new opportunities for manufacturers and healthcare providers alike.
Liquid Substance, Gelatine, Thrombin, Oxidized Regenerated Cellulose, Powder Hemostat in the Global Adjunctive Haemostats Market:
Liquid substances in the Global Adjunctive Haemostats Market are typically used to control bleeding by forming a physical barrier over the wound. These substances can be applied directly to the bleeding site, where they quickly form a gel-like layer that helps to stop the flow of blood. Gelatine-based haemostats are another popular option, derived from animal collagen. They work by absorbing blood and swelling to create a mechanical barrier that aids in clot formation. Thrombin, a naturally occurring enzyme in the blood, is often used in conjunction with other haemostatic agents to enhance their effectiveness. When applied to a bleeding site, thrombin converts fibrinogen to fibrin, which is a key component of blood clots. Oxidized regenerated cellulose is a plant-based material that is highly absorbent and can be left in the body after surgery, where it is gradually absorbed. It works by providing a scaffold for clot formation and is particularly useful in surgeries where traditional methods are challenging. Powder haemostats are finely ground substances that can be sprinkled over a bleeding site. They work by absorbing blood and forming a gel-like barrier that helps to stop bleeding. Each of these haemostatic agents has its unique properties and applications, making them valuable tools in the surgical toolkit.
Gynecology, Tumors, Cardiovascular, General Surgery in the Global Adjunctive Haemostats Market:
The usage of Global Adjunctive Haemostats Market products spans various medical fields, including gynecology, tumors, cardiovascular, and general surgery. In gynecology, haemostats are crucial during procedures such as hysterectomies, myomectomies, and cesarean sections. They help control bleeding from the uterus and other reproductive organs, ensuring patient safety and reducing the risk of complications. In tumor surgeries, haemostats are essential for managing bleeding from highly vascularized tissues. Tumors often have an extensive blood supply, making them prone to significant bleeding during removal. Haemostats help surgeons control this bleeding, allowing for safer and more effective tumor resection. In cardiovascular surgeries, such as coronary artery bypass grafting (CABG) and valve replacements, haemostats are used to control bleeding from blood vessels and heart tissues. These procedures often involve delicate and complex maneuvers, making effective haemostasis critical for patient outcomes. In general surgery, haemostats are used in a wide range of procedures, from appendectomies to liver resections. They help control bleeding from various tissues and organs, ensuring that surgeries can be completed safely and efficiently. The versatility and effectiveness of adjunctive haemostats make them indispensable in modern surgical practice, contributing to improved patient outcomes and reduced surgical complications.
Global Adjunctive Haemostats Market Outlook:
The global Adjunctive Haemostats market was valued at US$ 446 million in 2023 and is anticipated to reach US$ 669.3 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during the next six years. This growth is driven by the increasing demand for advanced medical technologies and the rising number of surgical procedures worldwide. The expanding healthcare infrastructure in emerging economies and the growing awareness of the benefits of adjunctive haemostats among healthcare professionals are also contributing to the market's growth. As the market continues to evolve, manufacturers are focusing on developing innovative products that offer improved efficacy and safety. This trend is expected to drive further growth in the global adjunctive haemostats market, providing new opportunities for industry players and healthcare providers alike.
| Report Metric | Details |
| Report Name | Adjunctive Haemostats Market |
| Accounted market size in 2023 | US$ 446 million |
| Forecasted market size in 2030 | US$ 669.3 million |
| CAGR | 6.0% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Baxter (Perclot), Johnson&Johnson (Ethicon Inc.), Biom'Up, BD, Pfizer, C.R.Bard,Inc., Grena Ltd, Schnell Medical |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
